DIAGNOSIS AND MODERN TREATMENT APPROACHES FOR DILATED CARDIOMYOPATHY

Authors

  • Zafar Panji ogli Tursunov Author

Keywords:

Dilated Cardiomyopathy, Heart Failure, Multimodality Imaging, Cardiac Magnetic Resonance, Guideline-Directed Medical Therapy, Implantable Cardioverter-Defibrillator, Left Ventricular Assist Device, Heart Transplantation

Abstract

Dilated cardiomyopathy (DCM) is a major subclass of cardiomyopathy characterized by left ventricular enlargement and systolic dysfunction, serving as a primary driver of progressive heart failure and sudden cardiac death. This review article comprehensively examines the contemporary diagnostic paradigm and modern therapeutic landscape of DCM. Modern diagnosis has transitioned from an exclusionary approach to a precise, etiology-driven framework utilizing advanced multimodality imaging, including echocardiography and cardiac magnetic resonance (CMR), alongside biomarker testing and genetic profiling. Treatment strategies rely on robust guideline-directed medical therapy (GDMT) including RAAS inhibitors, ARNIs, beta-blockers, and MRAs to promote reverse remodeling. For patients with persistent dysfunction, device therapies like implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) offer vital protection against arrhythmias and mechanical dyssynchrony. In end-stage refractory cases, mechanical circulatory support via left ventricular assist devices (LVADs) and orthotopic heart transplantation remain the definitive life-saving interventions. This article synthesizes these modern workflows into a cohesive clinical overview.

References

1. National Center for Biotechnology Information (NCBI). StatPearls: Dilated Cardiomyopathy. Treasure Island, FL: StatPearls Publishing. Available from: https://www.ncbi.nlm.nih.gov/

2. Mayo Clinic. Dilated Cardiomyopathy: Diagnosis and Treatment. Rochester, MN: Mayo Foundation for Medical Education and Research. Available from: https://www.mayoclinic.org/

3. McDonagh, T. A., Metra, M., Adamo, M., et al. (2021). 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European Heart Journal, 42(36), 3599–3726. https://doi.org/10.1093/eurheartj/ehab368

4. Heidenreich, P. A., Bozkurt, B., Aguilar, D., et al. (2022). 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology, 79(17), e263–e421. https://doi.org/10.1016/j.jacc.2021.12.012

5. Pinto, Y. M., Elliott, P. M., Ardissino, D., et al. (2016). Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases. European Heart Journal, 37(23), 1850–1858. https://doi.org/10.1093/eurheartj/ehv727

Published

2026-07-18